Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 14;10(7):e1305. doi: 10.1002/cti2.1305

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Intratumor expression of a cDC1 transcriptomic fingerprint and gene ontology annotations linked to CTL, helper T‐cell and IFN‐I/II signalling are all associated with a better prognosis in human breast cancer patients. (a, b) The Kaplan–Meier plot for human breast cancer patients based on the expression levels of a cDC1 gene signature in their tumor, for the TCGA data set (a) and for an independent compendium of breast cancer microarrays (b). (c, d) The Kaplan–Meier plot for the TCGA human breast cancer patients based on the expression levels of CCR7 (c) or CCL19 (d) in their tumor. (e) Gene Ontology analysis of a breast cancer good prognosis gene list. a–d were generated by using the KM plotter Web resource; e was retrieved from the Human Protein Atlas Web resource.